Sabine Gaugris

Sabine Gaugris possesses extensive experience in health economics and outcomes research, currently serving as Executive Director of HEOR & Access at FIECON since April 2018, after holding multiple positions including Director, Associate Director, and Senior Manager within the same field. Prior to FIECON, Sabine worked as a Senior HEOR / HTA Advisor at AbbVie from April 2015 to April 2018, and as a Senior Outcomes Research Manager at Janssen-Cilag from February 2008 to April 2014, focusing on hematology. Earlier career roles include various positions at Merck & Co., Inc. and Merck Sharp & Dohme France. Sabine holds a Master's degree in Health Economics from Université Paris Dauphine - PSL and a Master's degree in Biochemistry and Cellular Biology from Paris-Sud University (Paris XI).